The CXCL12/CXCR4/ACKR3 Response Axis in Chronic Neurodegenerative Disorders of the Central Nervous System: Therapeutic Target and Biomarker

被引：7

作者：

Yan, Yudie ^{[1
]}

Su, Jingtong ^{[2
]}

Zhang, Zhen ^{[1
]}

机构：

[1] China Med Univ, Affiliated Hosp 1, Dept Ultrasound, Shenyang 110001, Liaoning, Peoples R China

[2] Jinzhou Med Univ, Jinzhou City, Liaoning, Peoples R China

来源：

CELLULAR AND MOLECULAR NEUROBIOLOGY | 2022年 / 42卷 / 07期

基金：

中国国家自然科学基金;

关键词：

ACKR3; CXCL12; CXCR4; Neurodegenerative disorders; Central nervous system; ALZHEIMERS-DISEASE; CXCL12; EXPRESSION; CHEMOKINE CXCL12; MICROGLIA; MIGRATION; RECEPTOR; CELLS; MODEL; GLYCOSAMINOGLYCANS; DEFICIENT;

D O I：

10.1007/s10571-021-01115-1

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

There has been an increase in the incidence of chronic neurodegenerative disorders of the central nervous system, including Alzheimer's and Parkinson's diseases, over the recent years mostly due to the rise in the number of elderly individuals. In addition, various neurodegenerative disorders are related to imbalances in the CXCL12/CXCR4/ACKR3 response axis. Notably, the CXC Chemokine Ligand 12 (CXCL12) is essential for the development of the central nervous system. Moreover, the expression and distribution of CXCL12 and its receptors are associated with the aggravation or alleviation of symptoms of neurodegenerative disorders. Therefore, the current review sought to highlight the specific functions of CXCL12 and its receptors in various neurodegenerative disorders, in order to provide new insights for future research.

引用

下载

页码：2147 / 2156

页数：10

共 50 条

[1] The CXCL12/CXCR4/ACKR3 Response Axis in Chronic Neurodegenerative Disorders of the Central Nervous System: Therapeutic Target and Biomarker
Yudie Yan
Jingtong Su
Zhen Zhang
Cellular and Molecular Neurobiology, 2022, 42 : 2147 - 2156
[2] The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases
Garcia-Cuesta, Eva M.
Santiago, Cesar A.
Vallejo-Diaz, Jesus
Juarranz, Yasmina
Miguel Rodriguez-Frade, Jose
Mellado, Mario
FRONTIERS IN ENDOCRINOLOGY, 2019, 10
[3] The CXCL12/CXCR4/ACKR3 Axis in the Tumor Microenvironment: Signaling, Crosstalk, and Therapeutic Targeting
Smit, Martine J.
Schlecht-Louf, Geraldine
Neves, Maria
van den Bor, Jelle
Penela, Petronila
Siderius, Marco
Bachelerie, Francoise
Mayor, Federico, Jr.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021, 2021, 61 : 541 - 563
[4] Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3
Murphy, Philip M.
Heusinkveld, Lauren
CYTOKINE, 2018, 109 : 2 - 10
[5] Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12
del Barrio, Irene del Molino
Wilkins, Georgina C.
Meeson, Annette
Ali, Simi
Kirby, John A.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
[6] CXCR4/ACKR3/CXCL12 axis in the lymphatic metastasis of vulvar squamous cell carcinoma
Rusetska, Natalia
Kowalski, Kamil
Zalewski, Kamil
Zieba, Sebastian
Bidzinski, Mariusz
Goryca, Krzysztof
Kotowicz, Beata
Fuksiewicz, Malgorzata
Kopczynski, Janusz
Bakula-Zalewska, Elwira
Kowalik, Artur
Kowalewska, Magdalena
JOURNAL OF CLINICAL PATHOLOGY, 2022, 75 (05) : 324 - 332
[7] The CXCL12/CXCR4/ACKR3 Signaling Axis Regulates PKM2 and Glycolysis
Luker, Kathryn E.
Luker, Gary D.
CELLS, 2022, 11 (11)
[8] Crosstalk between CXCL12/CXCR4/ACKR3 and the STAT3 Pathway
Ma, Zelong
Zhou, Faxiao
Jin, Hua
Wu, Xiaoming
CELLS, 2024, 13 (12)
[9] Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12 (vol 19, 3592, 2018)
del Barrio, Irene del Molino
Wilkins, Georgina C.
Meeson, Annette
Ali, Simi
Kirby, John A.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (23)
[10] CXCL12/CXCR4/CXCR7 Chemokine Axis in the Central Nervous System: Therapeutic Targets for Remyelination in Demyelinating Diseases
Chu, Tianci
Shields, Lisa B. E.
Zhang, Yi Ping
Feng, Shi-Qing
Shields, Christopher B.
Cai, Jun
NEUROSCIENTIST, 2017, 23 (06): : 627 - 648

← 1 2 3 4 5 →